Magnetar Financial Acquires 10,425 Shares in Bio-Rad Laboratories

The institutional investor adds to its stake in the medical research company

Mar. 12, 2026 at 10:34am

Got story updates? Submit your updates here. ›

Magnetar Financial LLC acquired a new stake of 10,425 shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) during the 3rd quarter, according to a recent SEC filing. The shares were valued at approximately $2.92 million.

Why it matters

This purchase by Magnetar Financial, a prominent institutional investor, signals continued confidence in Bio-Rad Laboratories' prospects as a leading provider of life science research and clinical diagnostic products. The company's diverse product portfolio and global footprint have made it an attractive investment target.

The details

Magnetar Financial LLC added the 10,425 shares of Bio-Rad Laboratories to its portfolio in the 3rd quarter. This represents a new stake for the institutional investor in the medical research company. Bio-Rad Laboratories operates in two primary business segments: Life Science and Clinical Diagnostics, offering a range of instruments, reagents, and consumables used in various molecular biology applications as well as clinical testing.

  • Magnetar Financial acquired the 10,425 shares in the 3rd quarter of 2026.

The players

Magnetar Financial LLC

An institutional investor that acquired a new stake of 10,425 shares in Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

A global provider of life science research and clinical diagnostic products, operating in two primary business segments: Life Science and Clinical Diagnostics.

Got photos? Submit your photos here. ›

The takeaway

Magnetar Financial's investment in Bio-Rad Laboratories underscores the medical research company's strong market position and growth potential, as institutional investors continue to see value in its diversified product portfolio and global reach.